Exact Mass: 298.1699

Exact Mass Matches: 298.1699

Found 169 metabolites which its exact mass value is equals to given mass value 298.1699, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Fumigaclavine A

4,6-Dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetic acid

C18H22N2O2 (298.1681)


Fumigaclavine A is an alkaloid from Aspergillus fumigatu Fumigaclavine A. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=6879-59-0 (retrieved 2024-08-26) (CAS RN: 6879-59-0). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   

Artemether

3,12-Epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-trimethyl-, (3-alpha,5a-beta,6-beta,8a-beta,9-alpha,12-beta,12aR)-, (+)-

C16H26O5 (298.178)


Artemether is an artemisinin derivative that is artemisinin in which the lactone has been converted to the corresponding lactol methyl ether. It is used in combination with lumefantrine as an antimalarial for the treatment of multi-drug resistant strains of falciparum malaria. It has a role as an antimalarial. It is a sesquiterpenoid, a cyclic acetal, an organic peroxide, an artemisinin derivative and a semisynthetic derivative. Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. An artemisinin derivative that is used in the treatment of MALARIA. Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria. Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria.

   

Minaprine

3-(2-Morpholino-ethylamino)-4-methyl-6-phenyl pyridazine, dihydrochloride

C17H22N4O (298.1794)


Minaprine is a psychotropic drug which has proved to be effective in the treatment of various depressive states. Like most antidepressants minaprine antagonizes behavioral despair. Minaprine is an amino-phenylpyridazine antidepressant reported to be relatively free of cardiotoxicity, drowsiness, and weight gain. D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants

   

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

C18H22N2O2 (298.1681)


2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI is found in citrus. 2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI is an alkaloid from peelings of Citrus unshiu (satsuma mandarin). Alkaloid from peelings of Citrus unshiu (satsuma mandarin). 2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI is found in citrus.

   

9'-desmethylgranisetron

N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-1H-indazole-3-carboxamide

C17H22N4O (298.1794)


9-desmethylgranisetron is a metabolite of granisetron. Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. (Wikipedia)

   

3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-cyclohexanone

3,4-dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]cyclohexan-1-one

C16H26O5 (298.178)


   

alpha-Artemether

10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane

C16H26O5 (298.178)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria. Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria.

   

Carazolol

1-(9H-carbazol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol

C18H22N2O2 (298.1681)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Carazolol is a β1/β2 adrenoceptor antagonist of high potency used in the research of hypertension. Carazolol is also a potent, selective β3-adrenoceptor agonist[1].

   

Koninginin D

4,8-Dihydroxy-2-(1-hydroxyheptyl)-3,4,5,6,7,8-hexahydro-2H-1-benzopyran-5-one

C16H26O5 (298.178)


   

Hebelophyllene G

Hebelophyllene G

C16H26O5 (298.178)


   

Aigialone

Aigialone

C16H26O5 (298.178)


A furopyran that is 5,6-dihydro-4H-furo[2,3-b]pyran-3(2H)-one which is substituted by hydroxy groups at positions 4 and 5, methyl groups at positions 2 and 5, and a heptyl group at position 6 (the 2R,4R,5S,6R stereoisomer). Isolated from the mangrove fungus Aigialus parvus BCC 5311 and from Phaeoacremonium sp., an endophytic fungus from Senna spectabilis.

   

N,alpha,N,alpha-Cyclodi(4-methylaminobenzeneethanol)

N,alpha,N,alpha-Cyclodi(4-methylaminobenzeneethanol)

C18H22N2O2 (298.1681)


   

Carazolol

Carazolol

C18H22N2O2 (298.1681)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Carazolol is a β1/β2 adrenoceptor antagonist of high potency used in the research of hypertension. Carazolol is also a potent, selective β3-adrenoceptor agonist[1].

   

(2E)-4-Hydroxy-4-{4-hydroxy-2-[(1E)-6-hydroxy-1-hepten-1-yl]cyclopentyl}-2-butenoic acid

(2E)-4-Hydroxy-4-{4-hydroxy-2-[(1E)-6-hydroxy-1-hepten-1-yl]cyclopentyl}-2-butenoic acid

C16H26O5 (298.178)


   

Maybridge3_002255

Maybridge3_002255

C18H22N2O2 (298.1681)


   

C10-LAS (TENTATIVE)

C10-LAS (TENTATIVE)

C16H26O3S (298.1603)


TENTATIVELY IDENTIFIED SPECTRUM ONLY!!!!!!!!!; Extracted (without noise removal) from BIO_N: mz297_15_rt18_07_HCD60_C10-LAS; CONFIDENCE Tentative identification: isomers possible (Level 3)

   

CHEBI:167856

CHEBI:167856

C16H26O5 (298.178)


   

Methoxydoisuthine

Methoxydoisuthine

C18H22N2O2 (298.1681)


   

Strychnochromine

Strychnochromine

C18H22N2O2 (298.1681)


   
   

2-[(1S,8abeta)-1beta,5alpha,7alpha-Trihydroxy-4aalpha,8alpha-dimethyldecalin-2alpha-yl]acrylic acid methyl ester

2-[(1S,8abeta)-1beta,5alpha,7alpha-Trihydroxy-4aalpha,8alpha-dimethyldecalin-2alpha-yl]acrylic acid methyl ester

C16H26O5 (298.178)


   

6,9-Dimethyl-7-O-acetylergolin|9alpha-acetoxy-6,8beta-dimethyl-ergoline|Roquefortin A|roquefortine-A

6,9-Dimethyl-7-O-acetylergolin|9alpha-acetoxy-6,8beta-dimethyl-ergoline|Roquefortin A|roquefortine-A

C18H22N2O2 (298.1681)


   

plakortide I

plakortide I

C16H26O5 (298.178)


   

Bisaborosaol C1

Bisaborosaol C1

C16H26O5 (298.178)


   

Bisaborosaol D

Bisaborosaol D

C16H26O5 (298.178)


   

neosartolactone 7-methyl ester

neosartolactone 7-methyl ester

C16H26O5 (298.178)


   

1-(2,4a,8-trihydroxy-1,2,6-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)-3-hydroxy-1-propanone

1-(2,4a,8-trihydroxy-1,2,6-trimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)-3-hydroxy-1-propanone

C16H26O5 (298.178)


   

gracilioether J

gracilioether J

C16H26O5 (298.178)


   

4alpha,8alpha-dihydroxy-10alpha-methoxy-1alpha,5alpha,7alpha,11-betaH-guaia,6alpha,12olide

4alpha,8alpha-dihydroxy-10alpha-methoxy-1alpha,5alpha,7alpha,11-betaH-guaia,6alpha,12olide

C16H26O5 (298.178)


   
   

trans-2,5-bis<(p-hydroxyphenyl)methyl>piperazine|trans-2,5-bis[(p-hydroxyphenyl)methyl]piperazine

trans-2,5-bis<(p-hydroxyphenyl)methyl>piperazine|trans-2,5-bis[(p-hydroxyphenyl)methyl]piperazine

C18H22N2O2 (298.1681)


   

methyl 1beta,6alpha,15-trihydroxy-4beta,15-dihydrocostate

methyl 1beta,6alpha,15-trihydroxy-4beta,15-dihydrocostate

C16H26O5 (298.178)


   

dehydroodorin|Dehydroodorine

dehydroodorin|Dehydroodorine

C18H22N2O2 (298.1681)


   

methyl botryaloate

methyl botryaloate

C16H26O5 (298.178)


   

(E)-N-[4-(3-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-butyl]-3-phenyl-2-propenamide|aglairubine

(E)-N-[4-(3-methyl-2-oxo-2,5-dihydro-1H-pyrrol-1-yl)-butyl]-3-phenyl-2-propenamide|aglairubine

C18H22N2O2 (298.1681)


   

Artemether

Artemether (SM-224)

C16H26O5 (298.178)


P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BE - Artemisinin and derivatives, plain D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria. Artemether is an anti-malarial compound that targets drug-resistant strains of falciparum malaria.

   

C10-LAS (STANDARD MIX)

C10-LAS (STANDARD MIX)

C16H26O3S (298.1603)


Auto-extracted from standard mix; CONFIDENCE Tentative identification: isomers possible (Level 3)

   

C10-LAS (SAMPLE)

C10-LAS (SAMPLE)

C16H26O3S (298.1603)


Auto-extracted from 130925_neg_10.mzML; CONFIDENCE Tentative identification: isomers possible (Level 3)

   

C16H26O5_Pentanoic acid, 3-methyl-, 5-hydroxy-3-(hydroxymethyl)-6-(1-methylethyl)-2-oxo-3-cyclohexen-1-yl ester

NCGC00381331-01_C16H26O5_Pentanoic acid, 3-methyl-, 5-hydroxy-3-(hydroxymethyl)-6-(1-methylethyl)-2-oxo-3-cyclohexen-1-yl ester

C16H26O5 (298.178)


   

[5-hydroxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate

[5-hydroxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate

C16H26O5 (298.178)


   

(2S,4R,8S)-4,8-dihydroxy-2-[(1S)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydrochromen-5-one

(2S,4R,8S)-4,8-dihydroxy-2-[(1S)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydrochromen-5-one

C16H26O5 (298.178)


   

Roquefortine A

Roquefortine A

C18H22N2O2 (298.1681)


CONFIDENCE isolated standard

   

C10LAS

C10LAS

C16H26O3S (298.1603)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); One of several possible homologues; Digitised from figure: approximate intensities

   

minaprine

minaprine

C17H22N4O (298.1794)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants

   

(2S,4R,8S)-4,8-dihydroxy-2-[(1S)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydrochromen-5-one_major

(2S,4R,8S)-4,8-dihydroxy-2-[(1S)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydrochromen-5-one_major

C16H26O5 (298.178)


   

N-(9-azabicyclo[3.3.1]nonan-3-yl)-1-methylindazole-3-carboxamide

endo-N-9-azabicyclo[3.3.1]non-3-yl-1-methyl-1H-Indazole-3-carboxamide

C17H22N4O (298.1794)


   

granisetron impurity b

endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-Indazole-3-carboxamide

C17H22N4O (298.1794)


   

13,14-dihydro-15-keto-tetranor Prostaglandin D2

9α-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid

C16H26O5 (298.178)


   

Tetranor-PGE2

2,3,4,5-tetranor-9-oxo-11R,15S-dihydroxy-13E-prostenoic acid

C16H26O5 (298.178)


   

Tetranor-PGD2

2,3,4,5-tetranor-9S,15S-dihydroxy-11-oxo-13E-prostenoic acid

C16H26O5 (298.178)


   

Fumigaclavine A

4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


An ergot alkaloid produced by the fungus Aspergillus fumigatus that is ergoline which is substituted by methyl groups at the 6 and 8beta positions, and by an acetoxy group at the 9beta position.

   

N,a',N',a-Cyclodi(4-methylaminobenzeneethanol)

2,9-dimethyl-2,9-diazatricyclo[10.2.2.2^{5,8}]octadeca-1(14),5,7,12,15,17-hexaene-3,10-diol

C18H22N2O2 (298.1681)


   

13,14-dihydro-15-keto-tetranor PGE2

9,15-dioxo-11α-hydroxy-2,3,4,5-tetranor-prostanoic acid

C16H26O5 (298.178)


   

FA 16:3;O3

2,3,4,5-tetranor-9S,15S-dihydroxy-11-oxo-13E-prostenoic acid

C16H26O5 (298.178)


   

1-(4-AMINOPHENYL)METHANESULFONAMIDE

1-(4-AMINOPHENYL)METHANESULFONAMIDE

C18H22N2O2 (298.1681)


   

1-Carbazol-9-yl-3-(2-methoxy-ethylamino)-propan-2-ol

1-Carbazol-9-yl-3-(2-methoxy-ethylamino)-propan-2-ol

C18H22N2O2 (298.1681)


   

2-methyl-1-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]indole-3-carbaldehyde

2-methyl-1-[2-(4-methylpiperidin-1-yl)-2-oxoethyl]indole-3-carbaldehyde

C18H22N2O2 (298.1681)


   

3-[(4-tert-Butyl-2-methylphenoxy)methyl]phenylboronic acid

3-[(4-tert-Butyl-2-methylphenoxy)methyl]phenylboronic acid

C18H23BO3 (298.174)


   

4-[(4-tert-Butyl-2-methylphenoxy)methyl]phenylboronic acid

4-[(4-tert-Butyl-2-methylphenoxy)methyl]phenylboronic acid

C18H23BO3 (298.174)


   

butyl prop-2-enoate,ethene,oxiran-2-ylmethyl 2-methylprop-2-enoate

butyl prop-2-enoate,ethene,oxiran-2-ylmethyl 2-methylprop-2-enoate

C16H26O5 (298.178)


   

4-decylbenzenesulfonic acid

4-decylbenzenesulfonic acid

C16H26O3S (298.1603)


   

2-[(4-TERT-BUTYL-2-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID

2-[(4-TERT-BUTYL-2-METHYLPHENOXY)METHYL]PHENYLBORONIC ACID

C18H23BO3 (298.174)


   

Phenacaine

holocalin(p)

C18H22N2O2 (298.1681)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

ISOPROPYL 1,1-DIMETHYL-1,2,3,6-TETRAHYDROAZEPINO[4,5-B]INDOLE-5-CARBOXYLATE

ISOPROPYL 1,1-DIMETHYL-1,2,3,6-TETRAHYDROAZEPINO[4,5-B]INDOLE-5-CARBOXYLATE

C18H22N2O2 (298.1681)


   

1-Diphenylmethylazetidin-3-amine acetate

1-Diphenylmethylazetidin-3-amine acetate

C18H22N2O2 (298.1681)


   

2-[4-(1-METHYL-1-PHENYLETHYL)PHENOXY]PROPANOHYDRAZIDE

2-[4-(1-METHYL-1-PHENYLETHYL)PHENOXY]PROPANOHYDRAZIDE

C18H22N2O2 (298.1681)


   

N-cyclohexyl-2-(3-formyl-2-methylindol-1-yl)acetamide

N-cyclohexyl-2-(3-formyl-2-methylindol-1-yl)acetamide

C18H22N2O2 (298.1681)


   

(ALPHA,ALPHA-DIFLUORO)PHENYLACETICACIDETHYLESTER

(ALPHA,ALPHA-DIFLUORO)PHENYLACETICACIDETHYLESTER

C14H26N2O3Si (298.1713)


   

3-(3-CARBAZOL-9-YL-2-HYDROXY-PROPYLAMINO)-PROPAN-1-OL

3-(3-CARBAZOL-9-YL-2-HYDROXY-PROPYLAMINO)-PROPAN-1-OL

C18H22N2O2 (298.1681)


   

N-[2-[di(propan-2-yl)amino]ethyl]-4-methylbenzenesulfonamide

N-[2-[di(propan-2-yl)amino]ethyl]-4-methylbenzenesulfonamide

C15H26N2O2S (298.1715)


   

(-)-BIS[(S)-1-PHENYLETHYL]AMINEHYDROCHLORIDE

(2s)-1-(9h-Carbazol-4-Yloxy)-3-(Isopropylamino)propan-2-Ol

C18H22N2O2 (298.1681)


   

(+)-B-HYDRASTINEHCL

(+)-B-HYDRASTINEHCL

C18H22N2O2 (298.1681)


   

4-(4-AMINOMETHYL)PHENYL-1-N-BOC-ANILINE

4-(4-AMINOMETHYL)PHENYL-1-N-BOC-ANILINE

C18H22N2O2 (298.1681)


   

5-TERT-BUTYL 1-ETHYL 3-AMINO-3A,4,6,6A-TETRAHYDROPYRROLO[3,4-C]PYRAZOLE-1,5-DICARBOXYLATE

5-TERT-BUTYL 1-ETHYL 3-AMINO-3A,4,6,6A-TETRAHYDROPYRROLO[3,4-C]PYRAZOLE-1,5-DICARBOXYLATE

C13H22N4O4 (298.1641)


   

1,2-Ethanediamine,N1-[[[2-(trimethoxysilyl)ethyl]phenyl]methyl]-

1,2-Ethanediamine,N1-[[[2-(trimethoxysilyl)ethyl]phenyl]methyl]-

C14H26N2O3Si (298.1713)


   

tert-Butyl 4-(1H-indol-3-yl)-3,6-dihydropyridine-1(2H)-carboxylate

tert-Butyl 4-(1H-indol-3-yl)-3,6-dihydropyridine-1(2H)-carboxylate

C18H22N2O2 (298.1681)


   

2,4,6-Triisopropylbenzenesulfonyl Hydrazide

2,4,6-Triisopropylbenzenesulfonyl Hydrazide

C15H26N2O2S (298.1715)


   

albumin, horse

3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-one

C16H26O5 (298.178)


   

(4-(1-(4-ethylpiperazin-1-yl)ethyl)phenyl)boronic acid hydrochloride

(4-(1-(4-ethylpiperazin-1-yl)ethyl)phenyl)boronic acid hydrochloride

C14H24BClN2O2 (298.1619)


   

[3-[6-(piperidin-1-ylmethyl)pyridin-2-yl]oxyphenyl]methanol

[3-[6-(piperidin-1-ylmethyl)pyridin-2-yl]oxyphenyl]methanol

C18H22N2O2 (298.1681)


   

1-(2,3-DIMETHYL-INDOL-1-YL)-3-[(FURAN-2-YLMETHYL)-AMINO]-PROPAN-2-OL

1-(2,3-DIMETHYL-INDOL-1-YL)-3-[(FURAN-2-YLMETHYL)-AMINO]-PROPAN-2-OL

C18H22N2O2 (298.1681)


   

(S,S)-2,5-di-(4-hydroxybenzyl)piperazine

(S,S)-2,5-di-(4-hydroxybenzyl)piperazine

C18H22N2O2 (298.1681)


   

9-desmethylgranisetron

9-desmethylgranisetron

C17H22N4O (298.1794)


   

2-amino-4-(cyclohex-3-en-1-yl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile

2-amino-4-(cyclohex-3-en-1-yl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile

C18H22N2O2 (298.1681)


   

1-Methyl-N-(8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-1H-indazole-3-carboxamide

1-Methyl-N-(8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-1H-indazole-3-carboxamide

C17H22N4O (298.1794)


   

(-)-Aigialone

(-)-Aigialone

C16H26O5 (298.178)


   

Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester

Hexylphosphonic acid (R)-2-methyl-3-phenylpropyl ester

C16H27O3P (298.1698)


   

Hexylphosphonic acid (S)-2-methyl-3-phenylpropyl ester

Hexylphosphonic acid (S)-2-methyl-3-phenylpropyl ester

C16H27O3P (298.1698)


   

(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol

(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol

C18H22N2O2 (298.1681)


   

3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-cyclohexanone

3,4-Dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-cyclohexanone

C16H26O5 (298.178)


   

4,8-Dihydroxy-2-(1-hydroxyheptyl)-2,3,4,6,7,8-hexahydrochromen-5-one

4,8-Dihydroxy-2-(1-hydroxyheptyl)-2,3,4,6,7,8-hexahydrochromen-5-one

C16H26O5 (298.178)


   

4-(1-Propylheptyl)benzenesulfonic acid

4-(1-Propylheptyl)benzenesulfonic acid

C16H26O3S (298.1603)


   

Diphthinate

Diphthinate

C13H22N4O4 (298.1641)


An amino acid zwitterion that is the conjugate base of cationic diphthine, formed via deprotonation of both carboxy groups and protonation of the primary amino group; major species at pH 7.3.

   

(8beta,9beta)-6,8-Dimethylergolin-9-yl acetate

(8beta,9beta)-6,8-Dimethylergolin-9-yl acetate

C18H22N2O2 (298.1681)


   

N-(7-hydroxylgeranyl)-L-glutamate

N-(7-hydroxylgeranyl)-L-glutamate

C15H24NO5- (298.1654)


   

9-(4-Sulfophenyl)decane

9-(4-Sulfophenyl)decane

C16H26O3S (298.1603)


   

[(2S,3S,4R,5R)-5-[6-(dimethylamino)-6,7-dihydro-3H-purin-9-ium-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]azanium

[(2S,3S,4R,5R)-5-[6-(dimethylamino)-6,7-dihydro-3H-purin-9-ium-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]azanium

C12H22N6O3+2 (298.1753)


   

1-(3-Methoxyphenyl)-3-(4-phenylbutyl)urea

1-(3-Methoxyphenyl)-3-(4-phenylbutyl)urea

C18H22N2O2 (298.1681)


   

4-(2-Naphthalenylmethyl)-1-piperazinecarboxylic acid ethyl ester

4-(2-Naphthalenylmethyl)-1-piperazinecarboxylic acid ethyl ester

C18H22N2O2 (298.1681)


   

2-[[3-[(2-Hydroxyphenyl)methyl]-1,3-diazinan-1-yl]methyl]phenol

2-[[3-[(2-Hydroxyphenyl)methyl]-1,3-diazinan-1-yl]methyl]phenol

C18H22N2O2 (298.1681)


   

13,14-dihydro-15-keto-tetranor Prostaglandin E2

13,14-dihydro-15-keto-tetranor Prostaglandin E2

C16H26O5 (298.178)


   

(6R,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6S,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6R,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6R,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

(6R,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-7-[4-(1-cyclopentenyl)phenyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C18H22N2O2 (298.1681)


   

2,3,4,5-tetranor-15-oxoprostaglandin F2alpha

2,3,4,5-tetranor-15-oxoprostaglandin F2alpha

C16H26O5 (298.178)


A prostanoid that is prostaglandin F2alpha which is lacking two methylenes in the carboxyalkyl chain and in which the hydroxy group at position 15 has been oxidised to the corresponding ketone.

   

2-[3-carboxylato-3-(trimethylammonio)propyl]-L-histidine

2-[3-carboxylato-3-(trimethylammonio)propyl]-L-histidine

C13H22N4O4 (298.1641)


A L-histidine derivative that is L-histidine substituted at poisition 2 (on the imidazole ring) by a 3-carboxylato-3-(trimethylammonio)propyl group.

   

(2E,4R)-4-hydroxy-4-{(1R,2S,4S)-4-hydroxy-2-[(1E,6S)-6-hydroxyhept-1-en-1-yl]cyclopentyl}but-2-enoic acid

(2E,4R)-4-hydroxy-4-{(1R,2S,4S)-4-hydroxy-2-[(1E,6S)-6-hydroxyhept-1-en-1-yl]cyclopentyl}but-2-enoic acid

C16H26O5 (298.178)


   

(E)-4-hydroxy-4-[4-hydroxy-2-[(E)-6-hydroxyhept-1-enyl]cyclopentyl]but-2-enoic acid

(E)-4-hydroxy-4-[4-hydroxy-2-[(E)-6-hydroxyhept-1-enyl]cyclopentyl]but-2-enoic acid

C16H26O5 (298.178)


   

(2R,3S,4R,7S)-2-heptyl-3,4-dihydroxy-3,7-dimethyl-4,7-dihydro-2H-furo[3,4-b]pyran-5-one

(2R,3S,4R,7S)-2-heptyl-3,4-dihydroxy-3,7-dimethyl-4,7-dihydro-2H-furo[3,4-b]pyran-5-one

C16H26O5 (298.178)


   

[(1S)-1-carboxy-3-(4-hydroxy-3,5-dimethoxyphenyl)propyl]-trimethylazanium

[(1S)-1-carboxy-3-(4-hydroxy-3,5-dimethoxyphenyl)propyl]-trimethylazanium

C15H24NO5+ (298.1654)


   

2alpha-[(S)-1-Hydroxyheptyl]-4beta,8alpha-dihydroxy-3,4,7,8-tetrahydro-2H-1-benzopyran-5(6H)-one

2alpha-[(S)-1-Hydroxyheptyl]-4beta,8alpha-dihydroxy-3,4,7,8-tetrahydro-2H-1-benzopyran-5(6H)-one

C16H26O5 (298.178)


   

Artemether (SM-224)

Artemether (SM-224)

C16H26O5 (298.178)


   

5,6,7,14,15,16-Hexahydro-6,15-methanobenzo(A)naphtho(2,3-F)cyclodecene

5,6,7,14,15,16-Hexahydro-6,15-methanobenzo(A)naphtho(2,3-F)cyclodecene

C23H22 (298.1721)


   

(2S,3S)-4-Benzyloxy-2-methoxyethoxymethoxy-3-methylbutanol

(2S,3S)-4-Benzyloxy-2-methoxyethoxymethoxy-3-methylbutanol

C16H26O5 (298.178)


   

4,4-Hexamethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

4,4-Hexamethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

C18H22N2O2 (298.1681)


   

3,3,4-Trimethoxy-8,8,9,9-tetramethylbicyclo(5.2.0)nonane-2,6-dione

3,3,4-Trimethoxy-8,8,9,9-tetramethylbicyclo(5.2.0)nonane-2,6-dione

C16H26O5 (298.178)


   

2,2,3-Trimethoxy-6-(1,1,2-trimethyl-2-propenyl)cycloheptane-1,5-dione

2,2,3-Trimethoxy-6-(1,1,2-trimethyl-2-propenyl)cycloheptane-1,5-dione

C16H26O5 (298.178)


   

5-Methyl-4,4-tetramethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

5-Methyl-4,4-tetramethylene-2-para-tolylperhydropyrrolo(3,4-C)pyrrole-1,3-dione

C18H22N2O2 (298.1681)


   

[1-Carboxy-3-(4-hydroxy-3,5-dimethoxyphenyl)propyl]-trimethylazanium

[1-Carboxy-3-(4-hydroxy-3,5-dimethoxyphenyl)propyl]-trimethylazanium

C15H24NO5+ (298.1654)


   

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

2,9-Dimethyl-2,9-diazatricyclo[10.2.2.25,8]octadeca-5,7,12,14,15,17-hexaene-3,10-diol, 9CI

C18H22N2O2 (298.1681)


   

Tetranor-PGE1

Tetranor-PGE1

C16H26O5 (298.178)


   

Tetranor-PGD1

Tetranor-PGD1

C16H26O5 (298.178)


   

isoaigialone B

isoaigialone B

C16H26O5 (298.178)


A gamma-lactone that is 3,4,5,7-tetrahydro-2H-furo[3,4-b]pyran substituted by heptyl, methyl, hydroxy, hydroxy, oxo and methyl groups at positions 2R, 3S, 3S, 4R, 5 and 7R, respectively. It is isolated from the endophytic fungus Phaeoacremonium sp. and exhibits antifungal activities.

   

13,14-Dihydro-15-keto-tetranor-PGD2

13,14-Dihydro-15-keto-tetranor-PGD2

C16H26O5 (298.178)


   

methyl (5s,8r)-5-hydroxy-5-(hydroxymethyl)-8-[(2s)-1-hydroxypropan-2-yl]-4,4a,6,7,8,8a-hexahydro-3h-naphthalene-2-carboxylate

methyl (5s,8r)-5-hydroxy-5-(hydroxymethyl)-8-[(2s)-1-hydroxypropan-2-yl]-4,4a,6,7,8,8a-hexahydro-3h-naphthalene-2-carboxylate

C16H26O5 (298.178)


   

methyl 2-[(1s,2s,4ar,5r,7s,8r,8as)-1,5,7-trihydroxy-4a,8-dimethyl-octahydro-1h-naphthalen-2-yl]prop-2-enoate

methyl 2-[(1s,2s,4ar,5r,7s,8r,8as)-1,5,7-trihydroxy-4a,8-dimethyl-octahydro-1h-naphthalen-2-yl]prop-2-enoate

C16H26O5 (298.178)


   

bisaborosaol c1

NA

C16H26O5 (298.178)


{"Ingredient_id": "HBIN018587","Ingredient_name": "bisaborosaol c1","Alias": "NA","Ingredient_formula": "C16H26O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14481","TCMID_id": "2420","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

bisaborosaol c2

NA

C16H26O5 (298.178)


{"Ingredient_id": "HBIN018588","Ingredient_name": "bisaborosaol c2","Alias": "NA","Ingredient_formula": "C16H26O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14482","TCMID_id": "2421","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2s,3r,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2s,3r,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


   

9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

C18H22N2O2 (298.1681)


   

methyl 5-hydroxy-5-(hydroxymethyl)-8-(1-hydroxypropan-2-yl)-4,4a,6,7,8,8a-hexahydro-3h-naphthalene-2-carboxylate

methyl 5-hydroxy-5-(hydroxymethyl)-8-(1-hydroxypropan-2-yl)-4,4a,6,7,8,8a-hexahydro-3h-naphthalene-2-carboxylate

C16H26O5 (298.178)


   

(2s,3s,4s,7s)-2-heptyl-3,4-dihydroxy-3,7-dimethyl-2h,4h,7h-furo[3,4-b]pyran-5-one

(2s,3s,4s,7s)-2-heptyl-3,4-dihydroxy-3,7-dimethyl-2h,4h,7h-furo[3,4-b]pyran-5-one

C16H26O5 (298.178)


   

n-[2-(4-methoxyphenyl)ethyl]-n-methyl-2-(methylamino)benzamide

n-[2-(4-methoxyphenyl)ethyl]-n-methyl-2-(methylamino)benzamide

C18H22N2O2 (298.1681)


   

methyl 2-[3,3-dimethyl-2-(2,4,5-trihydroxy-3-methylidenepentyl)cyclobutyl]prop-2-enoate

methyl 2-[3,3-dimethyl-2-(2,4,5-trihydroxy-3-methylidenepentyl)cyclobutyl]prop-2-enoate

C16H26O5 (298.178)


   

1-[(1r,2r,4as,6s,8s,8as)-2,4a,8-trihydroxy-1,2,6-trimethyl-6,7,8,8a-tetrahydro-5h-naphthalen-1-yl]-3-hydroxypropan-1-one

1-[(1r,2r,4as,6s,8s,8as)-2,4a,8-trihydroxy-1,2,6-trimethyl-6,7,8,8a-tetrahydro-5h-naphthalen-1-yl]-3-hydroxypropan-1-one

C16H26O5 (298.178)


   

methyl (1s,3ar,4s,6r,7s,7as)-7-formyl-4,7a-dihydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

methyl (1s,3ar,4s,6r,7s,7as)-7-formyl-4,7a-dihydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

C16H26O5 (298.178)


   

6-heptyl-4,5-dihydroxy-2,5-dimethyl-2h,4h,6h-furo[2,3-b]pyran-3-one

6-heptyl-4,5-dihydroxy-2,5-dimethyl-2h,4h,6h-furo[2,3-b]pyran-3-one

C16H26O5 (298.178)


   

methyl 2-[(1s,2s,4ar,5r,8s,8as)-1,5-dihydroxy-8-(hydroxymethyl)-4a-methyl-octahydro-1h-naphthalen-2-yl]prop-2-enoate

methyl 2-[(1s,2s,4ar,5r,8s,8as)-1,5-dihydroxy-8-(hydroxymethyl)-4a-methyl-octahydro-1h-naphthalen-2-yl]prop-2-enoate

C16H26O5 (298.178)


   

(2r,4s,8r)-4,8-dihydroxy-2-[(1r)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydro-1-benzopyran-5-one

(2r,4s,8r)-4,8-dihydroxy-2-[(1r)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydro-1-benzopyran-5-one

C16H26O5 (298.178)


   

methyl 2-(1,5,7-trihydroxy-4a,8-dimethyl-octahydro-1h-naphthalen-2-yl)prop-2-enoate

methyl 2-(1,5,7-trihydroxy-4a,8-dimethyl-octahydro-1h-naphthalen-2-yl)prop-2-enoate

C16H26O5 (298.178)


   

(2e)-2-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]but-2-enimidic acid

(2e)-2-methyl-n-[(2r)-1-[(2e)-3-phenylprop-2-enoyl]pyrrolidin-2-yl]but-2-enimidic acid

C18H22N2O2 (298.1681)


   

4-acetyl-3,4-dimethyl-5-oxooxolan-2-yl octanoate

4-acetyl-3,4-dimethyl-5-oxooxolan-2-yl octanoate

C16H26O5 (298.178)


   

6-[3-(formyloxy)-4-hydroxy-4-methylcyclohexyl]-2-methylhept-5-enoic acid

6-[3-(formyloxy)-4-hydroxy-4-methylcyclohexyl]-2-methylhept-5-enoic acid

C16H26O5 (298.178)


   

(1r,9s,12s,18s)-9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

(1r,9s,12s,18s)-9-(2-hydroxyethyl)-8,15-diazapentacyclo[10.5.1.0¹,⁹.0²,⁷.0¹⁵,¹⁸]octadeca-2,4,6-trien-10-one

C18H22N2O2 (298.1681)


   

2-methyl-n-[1-(3-phenylprop-2-enoyl)pyrrolidin-2-yl]but-2-enimidic acid

2-methyl-n-[1-(3-phenylprop-2-enoyl)pyrrolidin-2-yl]but-2-enimidic acid

C18H22N2O2 (298.1681)


   

1-(2,4a,8-trihydroxy-1,2,6-trimethyl-6,7,8,8a-tetrahydro-5h-naphthalen-1-yl)-3-hydroxypropan-1-one

1-(2,4a,8-trihydroxy-1,2,6-trimethyl-6,7,8,8a-tetrahydro-5h-naphthalen-1-yl)-3-hydroxypropan-1-one

C16H26O5 (298.178)


   

(2s,4s,5r,6s)-6-heptyl-4,5-dihydroxy-2,5-dimethyl-2h,4h,6h-furo[2,3-b]pyran-3-one

(2s,4s,5r,6s)-6-heptyl-4,5-dihydroxy-2,5-dimethyl-2h,4h,6h-furo[2,3-b]pyran-3-one

C16H26O5 (298.178)


   

9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

C18H22N2O2 (298.1681)


   

6-[(1s,3s,4r)-3-(formyloxy)-4-hydroxy-4-methylcyclohexyl]-2-methylhept-5-enoic acid

6-[(1s,3s,4r)-3-(formyloxy)-4-hydroxy-4-methylcyclohexyl]-2-methylhept-5-enoic acid

C16H26O5 (298.178)


   

methyl 2-[1,5-dihydroxy-8-(hydroxymethyl)-4a-methyl-octahydro-1h-naphthalen-2-yl]prop-2-enoate

methyl 2-[1,5-dihydroxy-8-(hydroxymethyl)-4a-methyl-octahydro-1h-naphthalen-2-yl]prop-2-enoate

C16H26O5 (298.178)


   

5-hydroxy-3-[(1r)-1-hydroxy-8-methyl-6-oxodecyl]-4-methyl-5h-furan-2-one

5-hydroxy-3-[(1r)-1-hydroxy-8-methyl-6-oxodecyl]-4-methyl-5h-furan-2-one

C16H26O5 (298.178)


   

methyl 2-[(1s,2s)-3,3-dimethyl-2-[(2s,4s)-2,4,5-trihydroxy-3-methylidenepentyl]cyclobutyl]prop-2-enoate

methyl 2-[(1s,2s)-3,3-dimethyl-2-[(2s,4s)-2,4,5-trihydroxy-3-methylidenepentyl]cyclobutyl]prop-2-enoate

C16H26O5 (298.178)


   

(2s,4r,8r)-4,8-dihydroxy-2-[(1s)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydro-1-benzopyran-5-one

(2s,4r,8r)-4,8-dihydroxy-2-[(1s)-1-hydroxyheptyl]-2,3,4,6,7,8-hexahydro-1-benzopyran-5-one

C16H26O5 (298.178)


   

(1s,9s,10r,14r)-9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

(1s,9s,10r,14r)-9-(2-hydroxyethyl)-8,11-diazapentacyclo[9.5.2.0¹,¹⁰.0²,⁷.0⁹,¹⁴]octadeca-2,4,6-trien-16-one

C18H22N2O2 (298.1681)


   

(2e)-n-[4-(3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

(2e)-n-[4-(3-methyl-2-oxo-5h-pyrrol-1-yl)butyl]-3-phenylprop-2-enimidic acid

C18H22N2O2 (298.1681)


   

(2r,3s,4r,7r)-2-heptyl-3,4-dihydroxy-3,7-dimethyl-2h,4h,7h-furo[3,4-b]pyran-5-one

(2r,3s,4r,7r)-2-heptyl-3,4-dihydroxy-3,7-dimethyl-2h,4h,7h-furo[3,4-b]pyran-5-one

C16H26O5 (298.178)


   

(2r,3r,4r,7s)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2r,3r,4r,7s)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


   

(2r,3s,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2r,3s,4s,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)


   

11,12-dihydroxy-7-methoxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-5-one

11,12-dihydroxy-7-methoxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-5-one

C16H26O5 (298.178)


   

(1r,4s,7s,8s,9r,11s,12s)-11,12-dihydroxy-7-methoxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-5-one

(1r,4s,7s,8s,9r,11s,12s)-11,12-dihydroxy-7-methoxy-2,2,4,9-tetramethyl-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-5-one

C16H26O5 (298.178)


   

2-heptyl-3,4-dihydroxy-3,7-dimethyl-2h,4h,7h-furo[3,4-b]pyran-5-one

2-heptyl-3,4-dihydroxy-3,7-dimethyl-2h,4h,7h-furo[3,4-b]pyran-5-one

C16H26O5 (298.178)


   

methyl 7-formyl-4,7a-dihydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

methyl 7-formyl-4,7a-dihydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

C16H26O5 (298.178)


   

(2r,3r,4r,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

(2r,3r,4r,7r)-4,6-dimethyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraen-3-yl acetate

C18H22N2O2 (298.1681)